Dermatology CRO Market Size, Share & Trends Analysis Report - Improvements with Bottlenecking of Clinical Trials - Forecasts up to 2028

DUBLIN, Oct. 26, 2021 /PRNewswire/ -- The "Dermatology CRO Market Size, Share & Trends Analysis Report By Type (Preclinical, Clinical, Drug Discovery), By Service (Clinical Monitoring, Regulatory/Medical Affairs), By Region, and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering.

The global dermatology CRO market size is expected to reach USD 7.04 billion by 2028. It is expected to expand at a CAGR of 6.9% from 2021 to 2028. The rise in demand for topical dermatological medications, such as anti-inflammatory agents, anti-infective, local anesthetics, cleansers, and emollients, to treat acne is a major factor driving the market. Furthermore, increased awareness regarding skin diseases, high demand for speedy diagnosis, and an increase in the prevalence of skin cancer and other skin problems are all driving the industry forward.

The COVID-19 pandemic shook the economy in 2020 and has an ongoing impact on various industries across the globe. The market for dermatology contract research organizations (CRO) was largely unaffected by the repercussions of the pandemic owing to the emergence of virtual clinical trials and government initiatives to sustain the disrupted supply chains in healthcare. Moreover, with the ongoing vaccination drives and lifting of shelter in place mandates, the bottlenecking of clinical trials is improving. Thus, the future seems good for the market.

Factors such as increased investment in R&D programs, a preference for outsourcing tasks due to time and cost constraints, and patent expiration in the dermatology industry are some of the key factors expected to drive the market over the forecast period. Contract research outsourcing collaborations provide cutting-edge services, thus pharmaceutical players and government agencies prefer to delegate projects to dermatology CROs, allowing the market to develop.

Dermatology CRO Market Report Highlights

• Based on type, the clinical segment grabbed the largest revenue share of over 75.0% in 2020 owing to technological advancements, globalization of clinical trials, and the need for dermatology CROs to conduct clinical trials.
• In the clinical type segment, the phase III segment accounted for the largest revenue share of over 50.0% in 2020 as phase III clinical trials are the most expensive and involve a large patient pool.
• By service, clinical monitoring held the largest revenue share in 2020 owing to an increase in the number of clinical trials and the need to monitor those trials efficiently.
• Asia Pacific captured the largest revenue share of over 40.0% in 2020. This is due to the high prevalence of skin disorders, diversity in populations, the ease with which patients may be recruited and retained, and improving regulatory framework.

Companies Mentioned

• IQVIA
• Covance, Inc.
• Pharmaceutical Product development, Inc.
• Parexel International Corporation
• Charles River Laboratories International, Inc.
• Icon, Plc
• Syneos Health
• Wuxi Apptec
• Bioskin
• Proinnovera

Key Topics Covered:

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Research Methodology
1.3. Information Procurement
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Dermatology CRO Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.4. Dermatology CRO: Market Analysis Tools
3.4.2. PESTEL analysis

Chapter 4. Dermatology CRO Market: Segment Analysis, by Type, 2016 - 2028 (USD Million)
4.1. Dermatology CRO Market: Type Movement Analysis
4.2. Drug Discovery
4.2.1. Drug discovery market, 2016 - 2028 (USD Million)
4.2.1.1. Target Validation
4.2.1.1.1. Target validation market, 2016 - 2028 (USD Million)
4.2.1.2. Lead Identification
4.2.1.2.1. Lead identification market, 2016 - 2028 (USD Million)
4.2.1.3. Lead optimization
4.2.1.3.1. Lead optimization market, 2016 - 2028 (USD Million)
4.3. Preclinical
4.3.1. Preclinical market, 2016 - 2028 (USD Million)
4.4. Clinical
4.4.1. Clinical market, 2016 - 2028 (USD Million)

Chapter 5. Dermatology CRO Market: Segment Analysis, by Service, 2016 - 2028 (USD Million)
5.1. Dermatology CRO Market: Service Movement Analysis
5.2. Project Management/Clinical Supply Management
5.2.1. Project management/clinical supply management market, 2016 - 2028 (USD Million)
5.3. Data Management
5.3.1. Data management market, 2016 - 2028 (USD Million)
5.4. Regulatory/Medical Affairs
5.4.1. Regulatory/medical affairs market, 2016 - 2028 (USD Million)
5.5. Medical Writing
5.5.1. Medical writing market, 2016 - 2028 (USD Million)
5.6. Clinical Monitoring
5.6.1. Clinical monitoring market, 2016 - 2028 (USD Million)
5.7. Quality Management/ Assurance
5.7.1. Quality management/ assurance market, 2016 - 2028 (USD Million)
5.8. Bio-statistics
5.8.1. Bio-statistics market, 2016 - 2028 (USD Million)
5.9. Investigator Payments
5.9.1. Investigator payments market, 2016 - 2028 (USD Million)
5.10. Laboratory
5.10.1. Laboratory market, 2016 - 2028 (USD Million)
5.11. Patient and Site Recruitment
5.11.1. Patient & site recruitment market, 2016 - 2028 (USD Million)
5.12. Technology
5.12.1. Technology market, 2016 - 2028 (USD Million)
5.13. Others
5.13.1. Others market, 2016 - 2028 (USD Million)

Chapter 6. Dermatology CRO Market: Regional Market Analysis, 2016 - 2028 (USD Million)
6.1. Regional Market Dashboard
6.2. Regional Market Share Analysis, 2020 & 2028
6.3. North America
6.3.1. North America market estimates and forecast, 2016 - 2028 (USD Million)
6.3.2. U.S.
6.3.2.1. U.S. market estimates and forecast, 2016 - 2028 (USD Million)
6.3.3. Canada
6.3.3.1. Canada market estimates and forecast, 2016 - 2028 (USD Million)
6.4. Europe
6.4.1. Europe market estimates and forecast, 2016 - 2028 (USD Million)
6.4.2. U.K.
6.4.2.1. U.K. market estimates and forecast, 2016 - 2028 (USD Million)
6.4.3. Germany
6.4.3.1. Germany market estimates and forecasts, 2016 - 2028 (USD Million)
6.4.4. France
6.4.4.1. France market estimates and forecast, 2016 - 2028 (USD Million)
6.4.5. Italy
6.4.5.1. Italy market estimates and forecasts, 2016 - 2028 (USD Million)
6.4.6. Spain
6.4.6.1. Spain market estimates and forecast, 2016 - 2028 (USD Million)
6.5. Asia Pacific
6.5.1. Asia Pacific market estimates and forecast, 2016 - 2028 (USD Million)
6.5.2. India
6.5.2.1. India market estimates and forecast, 2016 - 2028 (USD Million)
6.5.3. Japan
6.5.3.1. Japan market estimates and forecasts, 2016 - 2028 (USD Million)
6.5.4. China
6.5.4.1. China market estimates and forecast, 2016 - 2028 (USD Million)
6.5.5. Australia
6.5.5.1. Australia market estimates and forecasts, 2016 - 2028 (USD Million)
6.5.6. South Korea
6.5.6.1. South Korea market estimates and forecast, 2016 - 2028 (USD Million)
6.6. Latin America
6.6.1. Latin America market estimates and forecast, 2016 - 2028 (USD Million)
6.6.2. Brazil
6.6.2.1. Brazil market estimates and forecast, 2016 - 2028 (USD Million)
6.6.3. Mexico
6.6.3.1. Mexico market estimates and forecasts, 2016 - 2028 (USD Million)
6.6.4. Argentina
6.6.4.1. Argentina market estimates and forecast, 2016 - 2028 (USD Million)
6.6.5. Colombia
6.6.5.1. Colombia market estimates and forecasts, 2016 - 2028 (USD Million)
6.6.6. Chile
6.6.6.1. Chile market estimates and forecast, 2016 - 2028 (USD Million)
6.7. MEA
6.7.1. MEA market estimates and forecast, 2016 - 2028 (USD Million)
6.7.2. South Africa
6.7.2.1. South Africa market estimates and forecast, 2016 - 2028 (USD Million)
6.7.3. Saudi Arabia
6.7.3.1. Saudi Arabia market estimates and forecasts, 2016 - 2028 (USD Million)
6.7.4. UAE
6.7.4.1. UAE market estimates and forecast, 2016 - 2028 (USD Million)
6.7.5. Iran
6.7.5.1. Iran market estimates and forecasts, 2016 - 2028 (USD Million)
6.7.6. Israel
6.7.6.1. Israel market estimates and forecast, 2016 - 2028 (USD Million)

Chapter 7. Dermatology CRO Market - Competitive Analysis

For more information about this report visit https://www.researchandmarkets.com/r/2p4rka

Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]      

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900 

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com